- Home
- ZTEK vs PRE Comparison
ZTEK vs PRE Comparison
Compare ZTEK & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTEK
- PRE
- Stock Information
- Founded
- ZTEK 2008
- PRE 2014
- Country
- ZTEK Canada
- PRE Hong Kong
- Employees
- ZTEK N/A
- PRE N/A
- Industry
- ZTEK Major Chemicals
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- ZTEK Industrials
- PRE Industrials
- Exchange
- ZTEK Nasdaq
- PRE Nasdaq
- Market Cap
- ZTEK 91.6M
- PRE 102.7M
- IPO Year
- ZTEK N/A
- PRE N/A
- Fundamental
- Price
- ZTEK $0.76
- PRE $7.60
- Analyst Decision
- ZTEK
- PRE Buy
- Analyst Count
- ZTEK 0
- PRE 1
- Target Price
- ZTEK N/A
- PRE $9.00
- AVG Volume (30 Days)
- ZTEK 33.4K
- PRE 40.5K
- Earning Date
- ZTEK 08-14-2025
- PRE 10-06-2025
- Dividend Yield
- ZTEK N/A
- PRE N/A
- EPS Growth
- ZTEK N/A
- PRE N/A
- EPS
- ZTEK N/A
- PRE N/A
- Revenue
- ZTEK $678,078.00
- PRE $41,520,000.00
- Revenue This Year
- ZTEK N/A
- PRE $198.17
- Revenue Next Year
- ZTEK N/A
- PRE $59.73
- P/E Ratio
- ZTEK N/A
- PRE N/A
- Revenue Growth
- ZTEK 2519.47
- PRE 78.72
- 52 Week Low
- ZTEK $0.50
- PRE $3.10
- 52 Week High
- ZTEK $1.84
- PRE $11.99
- Technical
- Relative Strength Index (RSI)
- ZTEK 30.42
- PRE 44.57
- Support Level
- ZTEK $0.82
- PRE $7.27
- Resistance Level
- ZTEK $0.88
- PRE $8.04
- Average True Range (ATR)
- ZTEK 0.06
- PRE 0.40
- MACD
- ZTEK 0.01
- PRE -0.04
- Stochastic Oscillator
- ZTEK 4.00
- PRE 30.41
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.